Skip to main content
. 2023 May 15;13(6):3862–3872. doi: 10.21037/qims-22-1307

Table 2. Obtained the distribution of benign and malignant nodules corresponding to each score value, and classification of ACR TIRADS and R-TIRADS.

Score Percentage of benign nodules Percentage of Malignant Nodules ACR TIRADS (percentage of malignant nodules) Revised TIRADS (percentage of malignant nodules)
0 7/7 (100.00) 0/7 (0.00) 0/7 (0.00) TR 1, 0/7 (0.00)
2 25/26 (96.15) 1/26 (3.85) 1/26 (3.85) TR 2, 1/26 (3.85)
3 33/36 (91.67) 3/36 (8.33) 3/36 (8.33) TR 3, 3/36 (8.33)
4 37/48 (77.08) 11/48 (22.92) TR 4, 32/111 (28.83) TR 4a, 32/111 (28.83)
5 17/23 (73.91) 6/23 (26.09)
6 25/40 (62.50) 15/40 (37.50)
7 15/46 (32.61) 31/46 (67.39) TR 5, 193/245 (78.78) TR 4b, 44/68 (64.71)
8 9/22 (40.91) 13/22 (59.09)
9 11/66 (16.67) 55/66 (83.33) TR 5, 149/177 (84.18)
10 9/46 (19.57) 37/46 (80.43)
11 2/13 (15.38) 11/13 (84.62)
12 2/24 (8.33) 22/24 (91.67)
13 4/24 (16.67) 20/24 (83.33)
14 0/2 (0.00) 2/2 (100.00)
15 0/2 (0.00) 2/2 (100.00)

Data are shown as n/total (%). ACR, American College of Radiology; TIRADS(TR), Thyroid Imaging Reporting and Data System; R-TIRADS, revised Thyroid Imaging Reporting and Data System.